Abiomed (ABMD) Tops Q3 EPS by 22c, Offers Q4 Guidance
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Nonoperating Income (Expense), Total: 228K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Nonoperating Income (Expense), Total: 228K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Abiomed (NASDAQ: ABMD) reported Q3 EPS of $1.35, $0.22 better than the analyst estimate of $1.13. Revenue for the quarter came in at $231.7 million versus the consensus estimate of $225.59 million.
GUIDANCE:
Abiomed sees Q4 2021 revenue of $225-235 million, versus the consensus of $230.96 million.
For earnings history and earnings-related data on Abiomed (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
- Omega Flex (OFLX) Tops Q2 EPS by 27c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
